2Hill J M, Zalos G, Halcox J P, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med,2003, 348(7) :593.
3Walter D H, Rittig K, Bahlmann F H, etal. Statin therapy accelerate reendothelialization. Circulation, 2002, 105(25): 3017.
4Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000, 97(7): 3422.
5Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progentor cells inversely correlate with risk factors for coronary artery disease. Cir Res, 2001, 89(1): E1.
6Tepper O M, Galiano D R, CaplaJ M, etal. Human endothelial progenitor cells from type Ⅱ diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation, 2002,106(22) :2781.
7Asahara T, Murohara T, Sullivan A, et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science, 1997, 275(5302): 964.
8Peichev M, Naiyer A J, Pereira D, et al. Expression of VEGFR-2and AC133 by circulating human CD34(+) cells identifies a population offunctional endothelial precursors. Blood, 2000, 95 (3): 952.
9MuroharaT, Tepper O, SilverM, etal. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization. Exp Hematol, 2002, 30(8) :967.
10SuzukiT, Nishida M, FutamiS, et al. Neoendothelialization after peripheral blood stem cell transplantation in humans. A ease report of a Tokaimura nuclear accident victim. Cardiovasc Res, 2003, 58 (2):487.
